Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 63

Tests names and labsConditionsGenes and analytesMethods

SGCA Gene Sequencing

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
11
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
4630
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Deletion/Duplication Panel

Genetic Services Laboratory University of Chicago
United States
3925
  • D Deletion/duplication analysis

MyoGene Panel (43 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
9543
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Muscular Dystrophy (LGMD/EDMD) Panel (25 Genes)

Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine
United States
6425
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Limb-girdle muscular dystrophy, autosomal recessive type 2D

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15391578
  • C Sequence analysis of the entire coding region

SGCA. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

SGCA. Sequencing of the exons 3 and 5

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

Limb-Girdle Muscular Dystrophy (LGMD) NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
2324
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Recessive Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
1718
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Limb Girdle Muscular Dystrophy, Type 2D (LGMD2D) via the SGCA Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Family Prep Screen

Counsyl
United States
112110
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Cardiomyopathy and Skeletal Muscle Disease Panel

Invitae
United States
190150
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Muscular Dystrophy Panel

Invitae
United States
5555
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Limb-Girdle Muscular Dystrophy Panel

Invitae
United States
2633
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Neuromuscular Disorders Panel

Invitae
United States
141116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

LIMB-GIRDLE MUSCULAR DYSTROPHY, A.R.

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
2318
  • C Sequence analysis of the entire coding region

LIMB-GIRDLE MUSCULAR DYSTROPHY

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
2722
  • C Sequence analysis of the entire coding region

Neuromuscular Disorders Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
9988
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 63

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.